Suncoast Equity Management Has Raised Its Apple (AAPL) Position by $569,133; As Biogen (BIIB) Share Price Rose, Shareholder Tekla Capital Management Has Cut Its Position

Apple Inc. (NASDAQ:AAPL) Logo

Suncoast Equity Management increased its stake in Apple Inc (AAPL) by 3.52% based on its latest 2019Q2 regulatory filing with the SEC. Suncoast Equity Management bought 2,889 shares as the company’s stock rose 1.20% . The institutional investor held 85,027 shares of the computer manufacturing company at the end of 2019Q2, valued at $16.83M, up from 82,138 at the end of the previous reported quarter. Suncoast Equity Management who had been investing in Apple Inc for a number of months, seems to be bullish on the $ market cap company. The stock increased 1.19% or $3.1 during the last trading session, reaching $262.55. About 9.47 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 12.18% since December 4, 2018 and is uptrending. It has outperformed by 12.18% the S&P500. Some Historical AAPL News: 07/05/2018 – BUFFETT SAYS LEADERS OF OTHER COUNTRIES ARE SMART ENOUGH TO REALIZE IT IS IN THEIR INTEREST TO PROMOTE TRADE; 24/04/2018 – GBH’s Ives Sees Uphill Battle for Apple Going Into Earnings (Video); 12/04/2018 – VirnetX: Jury Finds Apple Willfully Infringed on Patents; 01/05/2018 – Apple said it sold 52.2 million iPhones in the quarter ended March, up from 51 million a year ago; 13/03/2018 – Apple to Hold Annual Software Developer Conference June 4 to 8; 04/05/2018 – Apple’s $100bn share buyback plan; 30/05/2018 – Apple released iOS 11.4 this week which includes a new Messages in iCloud feature; 23/05/2018 – Apple offers $50 credit for 2017 battery replacements; 19/04/2018 – Snore-Stopper and Silent Wake Up Prime Features of Brand New Sleep Cycle App for Apple Watch; 11/04/2018 – New York Post: Zuckerberg was ready to clap back at Apple on Capitol Hill

Tekla Capital Management Llc decreased its stake in Biogen Inc. (BIIB) by 28.51% based on its latest 2019Q2 regulatory filing with the SEC. Tekla Capital Management Llc sold 89,588 shares as the company’s stock rose 3.63% . The institutional investor held 224,690 shares of the biological products (no diagnostic substances) company at the end of 2019Q2, valued at $52.55M, down from 314,278 at the end of the previous reported quarter. Tekla Capital Management Llc who had been investing in Biogen Inc. for a number of months, seems to be less bullish one the $52.57 billion market cap company. The stock increased 0.22% or $0.64 during the last trading session, reaching $291.35. About 918,280 shares traded. Biogen Inc. (NASDAQ:BIIB) has declined 28.25% since December 4, 2018 and is downtrending. It has underperformed by 28.25% the S&P500. Some Historical BIIB News: 17/04/2018 – Biogen Builds on Its 40-Year Legacy in Neuroscience with Presentation of Research from Its Portfolio of Medicines and; 07/03/2018 – Biogen, AbbVie’s Zinbryta, Yanked From Market, Connected To Three U.S. Cases Of Brain Inflammation — MarketWatch; 27/04/2018 – Biogen Closes Above 50-Day Moving Average: Technicals; 20/04/2018 – BIOGEN INC – IN COLLABORATION, IONIS WILL BE RESPONSIBLE FOR IDENTIFICATION OF ANTISENSE DRUG CANDIDATES BASED ON SELECTED TARGETS; 05/04/2018 – BIOGEN – UNDER TERMS OF AGREEMENT, ABBVIE WILL GRANT PATENT LICENSES FOR USE AND SALE OF IMRALDI IN EUROPE, ON A COUNTRY-BY-COUNTRY BASIS; 12/03/2018 – Biogen To Buy Schizophrenia Treatment From Pfizer For Up To $590 Million — MarketWatch; 22/05/2018 – Biogen at Bernstein Strategic Decisions CEO Conference May 30; 24/04/2018 – Biogen: 1Q Revenue Growth Principally Driven by Spinraza, Which Contributed $364M in Global Rev; 27/03/2018 – ICCR: Shareholders Will Vote on Resolutions at AbbVie, Amgen, Biogen, Bristol-Myers Squibb and Eli Lilly; 13/04/2018 – Biogen’s Tecfidera Weekly Retail Sales Rose 0.5%: Symphony

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Nasdaq.com which released: “Apple Might Launch 4 — Not 3 — New iPhones in 2020 – Nasdaq” on December 03, 2019, also Nasdaq.com with their article: “Technology Sector Update for 11/12/2019: SE, KEM, AEIS, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” published on November 12, 2019, Nasdaq.com published: “Technology Sector Update for 11/25/2019: MSFT, AAPL, IBM, CSCO, GOOG, XPO, NIU, UBER – Nasdaq” on November 25, 2019. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Seekingalpha.com and their article: “Apple Now Borrows Free Money – Seeking Alpha” published on November 12, 2019 as well as Seekingalpha.com‘s news article titled: “Apple: Path To $300 And Beyond – Seeking Alpha” with publication date: November 13, 2019.

Investors sentiment decreased to 0.72 in Q2 2019. Its down 0.24, from 0.96 in 2019Q1. It dropped, as 60 investors sold AAPL shares while 954 reduced holdings. 139 funds opened positions while 596 raised stakes. 2.54 billion shares or 1.94% less from 2.60 billion shares in 2019Q1 were reported. Mariner Ltd Liability reported 702,522 shares. Ws Lllp holds 114,264 shares or 1.47% of its portfolio. Legg Mason Asset (Japan) stated it has 17,000 shares or 3.79% of all its holdings. Middleton Ma stated it has 124,190 shares. Kcm invested 3.39% of its portfolio in Apple Inc. (NASDAQ:AAPL). Seven Post Office LP reported 1,850 shares stake. Peavine Capital Lc, a Nevada-based fund reported 6,996 shares. Lvm Mngmt Mi holds 146,335 shares. American Inv Advsrs Limited Liability Corp has 34,151 shares. Van Hulzen Asset Mgmt Lc stated it has 5.5% of its portfolio in Apple Inc. (NASDAQ:AAPL). Ibm Retirement Fund holds 2.93% or 78,827 shares in its portfolio. Thornburg Mngmt reported 209,509 shares. Meritage has 3.78% invested in Apple Inc. (NASDAQ:AAPL) for 187,445 shares. Regal Investment Advsr Lc accumulated 35,041 shares or 1.35% of the stock. Thrivent For Lutherans holds 1.38% in Apple Inc. (NASDAQ:AAPL) or 2.30 million shares.

Suncoast Equity Management, which manages about $229.33M and $488.24 million US Long portfolio, decreased its stake in Paypal Hldgs Inc by 61,052 shares to 195,049 shares, valued at $22.33M in 2019Q2, according to the filing.

Investors sentiment decreased to 0.7 in Q2 2019. Its down 0.18, from 0.88 in 2019Q1. It dropped, as 82 investors sold BIIB shares while 316 reduced holdings. 78 funds opened positions while 202 raised stakes. 153.48 million shares or 6.01% less from 163.29 million shares in 2019Q1 were reported. Metropolitan Life Insurance Ny stated it has 38,284 shares or 0.16% of all its holdings. Baxter Bros holds 994 shares or 0.05% of its portfolio. 79,661 were reported by Artemis Invest Llp. Hexavest invested 0.3% in Biogen Inc. (NASDAQ:BIIB). Glob Endowment Mngmt Limited Partnership reported 8,690 shares. The Kansas-based Creative Planning has invested 0.02% in Biogen Inc. (NASDAQ:BIIB). Omers Administration invested in 26,500 shares or 0.07% of the stock. Cim Inv Mangement Inc reported 1,516 shares. Balyasny Asset Management Ltd Liability Corporation, Illinois-based fund reported 120,457 shares. Prudential Pcl has invested 0.12% in Biogen Inc. (NASDAQ:BIIB). Finemark Comml Bank & stated it has 2,807 shares or 0.04% of all its holdings. Korea Invest Corporation stated it has 0.19% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Wetherby Asset Management holds 0.09% or 3,346 shares in its portfolio. 37,392 were reported by Texas Permanent School Fund. Oakbrook Invests Ltd Liability Corporation has 0.09% invested in Biogen Inc. (NASDAQ:BIIB).

Tekla Capital Management Llc, which manages about $1.06 billion and $2.45 billion US Long portfolio, upped its stake in Agios Pharmaceuticals Inc. (NASDAQ:AGIO) by 53,566 shares to 145,342 shares, valued at $7.25M in 2019Q2, according to the filing. It also increased its holding in Edwards Lifesciences Corp. (NYSE:EW) by 12,971 shares in the quarter, for a total of 69,769 shares, and has risen its stake in Inogen Inc. (NASDAQ:INGN).

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.